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Background and purpose of the study: The goal was to evaluate and compare the effects of aqueous extract of
the seeds of chicory, Cichorium intybus L., on glucose tolerance test (GTT) and blood biochemical indices of
experimentally-induced hyperglycemic rats.
Methods: Late stage and early stage of Type 2 diabetes mellitus (T2DM) were induced in rats by streptozotocin
(STZ) and a combination of STZ and niacinamide (NIA/STZ), respectively. Within each group, one subgroup received
daily i. p. injections of chicory extract (125 mg/kg body weight, for 28 days). Body weight and fasting blood sugar
(FBS) were measured weekly. Blood was analyzed for glycosylated hemoglobin (HbA1c) and sera for alanine
aminotransferase (ALT), aspartate aminotransferase (AST), nitric oxide (NO), triacylglycerol (TG), total cholesterol (TC),
total protein, and insulin on days 10 and 28 after treatment. Intraperitoneal glucose tolerance test (IPGTT) along
with insulin determination was performed on a different set of rats in which the chicory-treated groups received
the extract for 10 days.
Results: During 4 weeks of treatment, chicory prevented body-weight loss and decreased FBS. ALT activities and
levels of TG, TC and HbA1c decreased, and concentration of NO increased in the chicory treated groups (p < 0.05).
Unlike late-stage diabetes, fasting serum insulin concentrations were higher and GTT pattern approximated to
normal in chicory-treated early-stage diabetic rats.
Conclusions: Chicory appeared to have short-term (about 2 hours, as far as GTT is concerned) and long-term
(28 days, in this study) effects on diabetes. Chicory may be useful as a natural dietary supplement for slowing
down the pace of diabetes progress, and delaying the development of its complications.
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The number of individuals with Type 2 diabetes mellitus
(T2DM) is increasing with a rate of three new cases
every ten seconds (International Diabetes Federation's
5th edition of the Diabetes Atlas, 2011); and it is being
diagnosed at younger age. Multiple risk factors behind
the disease include chronic stress and depression [1,2],
environmental pollutants and poisons [3], obesity and* Correspondence: anowrouzi@tums.ac.ir
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distribution, and reproduction in any mediumover-nutrition, and sedentary life style [4]; and the early
onset may be exacerbated by Barker’s “Fetal origins of
adult disease” hypothesis which calls to attention the
impact on the offspring of the presence and severity of
the risk factors in the pregnant mother [5].
Despite a multiplicity of drugs to affect proper blood
glucose control [6], there is a tendency among the
patients to seek additional remedy in traditional antidia-
betic plant extracts. Medicinal plants appear to benefit
diabetes in many ways [7,8]. Cichorium intybus L., com-
monly known as Chicory or Kasni (among Iranian folk),
has been used in traditional medicine to treat a variety
of diseases including high blood sugar [9-11]. Whole
plant ethanolic extract was reported to decrease serumtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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cose 6-phosphatase [12]. Chicoric acid from chicory and
basil leaves was found to enhance insulin release by pan-
creatic β cells and glucose uptake by muscle cells in cul-
ture [13]. Chicory has ameliorating effects against
various liver toxicities [14-16] and oxidative stress [17].
Ethanolic seed extract rich in caffeoylquinic acid has
recently been reported to improve glycemia in rats [18];
and a mixture of the aqueous extracts of six medicinal
plants including chicory combined with stirred yoghurt
filtrate was shown to protect against alloxan-induced
oxidative stress and diabetes in rats [19]. However,
chicory’s effects on early and late stage of diabetes have
not been addressed and compared before.
Previously, we reported the effects of drinking intact
chicory seed concoction on two diabetic patients. A 30%
reduction in blood sugar (408 mg/dl to 286mg/dl) within
one hour, and quick improvement in the state of fatigue
and lethargy were observed in the patient who was on
regular insulin (20 units Regular, 28 units NPH; daily)
and metformin (two, daily), while it took 3 hours for
the other patient who was not on drug or insulin ther-
apy to experience the same percent decrease in blood
sugar [20].
The present study was designed to investigate in more
detail the differences between early and late stages
of diabetes with regard to chicory’s effects on blood sugar
and some other blood parameters that deviate in diabetes.
Material and methods
Materials
Chicory seeds were purchased from Bazar Bozorg
Popular Market, Tehran, Iran and authenticated by Dr.
Amin, a botanist of the Faculty of Pharmacy; Tehran
University of Medical Sciences, with a voucher number
PMP-710. STZ and NIA were purchased from Sigma
(USA) and citrate buffer was obtained from Fluka (USA).
Crude extract preparation
Chicory seeds were cleaned and powdered using an elec-
tric mill. Every 200 g was soaked in 1L of distilled water
and refluxed for 20 minutes in a boiling water bath
to make a 20% solution. The solution was allowed to
cool at room temperature before being vacuum filtered
through Watman No 1 filter paper. The filtrate was
lyophilized at the Department of Physiology, School of
Medicine, Tehran University of Medical Sciences, with-
out further processing and stored at −20°C; every 100 g
of powdered seed yielded about 8.2 g of lyophilized sub-
stance. The crude extract was not sterilized.
Animals
All experiments were performed in the animal lab of the
Faculty of Pharmacy with nine-week-old male Wistar-Albino rats weighing 200–250 g and with normal FBS
levels around 86 ± 8 mg/dl. The animals were main-
tained in a temperature room (22 ± 2°C), with 12 h
light/dark cycle and fed with standard rat chow and
water ad libitum. Following several days of accli-
matization, rats were randomly assigned to control and
experimental groups. All ethical guidelines for use of
laboratory animals were followed carefully.
The study involved three groups of rats (n = 28); one
group of non-diabetic rats (Normal), and two groups of
rats with diabetes; i.e., late-stage diabetic (STZ-diabetic
rats), and early stage diabetic (NIA/STZ-diabetic rats).
The study was ethically approved by TUMS (Tehran
University of Medical Sciences) Review Board.
Experimental diabetes induction
The two models of experimental diabetes were devel-
oped in rats after overnight fasting (8 h) as follows.
Late stage (advanced) diabetes was induced by a single
dose of STZ (65mg/kg body weight) [21]; this group was
called the “STZ” group. Early stage diabetes, which we
called “NIA/STZ” group, was developed using a combin-
ation of STZ and niacinamide (NIA) according to modi-
fied Masiello method, where, an injection of STZ
(65mg/kg body weight) was followed 15 minutes later,
by an injection of niacinamide (NIA) (200mg/kg body
weight) [22-24] in one step only. Both STZ and NIA
were freshly prepared in 20 mM cold sodium citrate
buffer solution (pH 4.5) and injected, intraperitoneally,
with insulin needles.
Four days after injection, signs of severe and mild dia-
betes were detected, including bad smelling polyuria,
polydipsia, aggressiveness, and restlessness. Diabetes
induction was further confirmed by FBS measurement
(Table 1). After confirmation of diabetes, each group
was divided into, control and test, subgroups (n = 14) as
shown in Table 1.
Chicory treatment
Rats that were assigned to chicory-treated subgroups
received daily i. p. injections of chicory (125 mg/kg body
weight dissolved in 20-units volume of insulin syringe
of normal saline) according to Pushparaj et al. [12]
even though they had used whole plant ethanolic
extract. The treatment started on the fifth day after
induction of diabetes and lasted for 28 days. Table 1 pro-
vides a summary of group and subgroup divisions, initial
weights, initial non-fasting blood sugar, and FBS after
diabetes induction.
The dosage mentioned above was chosen also after
a pilot experiment with limited numbers of STZ-treated
rats (2 rats in two groups). Two doses of 40 and
100 mg/kg body weight were used. During 90 minute
follow up of blood sugar in normally fed rats at a
Table 1 A summary of the method: group divisions of rats, initial conditions and injections
Group name Initial Initial FBS (mg/dl) IP Chicory Injection
(Sample size) a Non-fasting BS (mg/dl) Weight (g) 4 days after diabetes induction (28 days)
Control (10) 110.64 ± 5.62 200.36 ± 17.86 86.5 ± 7.17 -
Chicory-control (10) 104.14 ± 10.99 219.28 ± 15.42 87.64 ± 9.41 +
NIA/STZ (9) 111.35 ± 7.56 228.00 ± 13.94 137.78 ± 15.62 -
Chicory-NIA/STZ (10) 111.28 ± 6.82 231.71 ± 14.87 137.00 ± 29.39 +
STZ (7) 107.93 ± 11.29 213.71 ± 21.24 308.50 ± 117.7 -
Chicory-STZ (10) 110.92 ± 2.59 230.28 ± 16.24 330.14 ± 109.54 +
BS, blood sugar; FBS, fasting blood sugar; STZ, Streptozotocin, 65 mg/kg body weight; NIA, Niacinamide, 200 mg/kg body weight,15 min later; IP, intraperitoneal;.
a refers to the number of animals on day 28 after treatment.
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dose caused greater reduction of blood sugar. Blood
sugar, (measured as explained below) decreased from 536
mg/dl down to 399 mg/dl, and from 510 mg/dl to 409
mg/dl with 100 and 40 mg/kg body weight of chicory ex-
tract, respectively. Normal saline and the previously mea-
sured quantity of the extract powder were mixed in
Eppendorf tubes by a vortex mixer and injected immedi-
ately, to reduce the possibility of bacterial contamination.
Despite many repeated i.p. injections, side effects, such
as abdominal adhesions, were not observed in the
treated rats.
Weekly measurements
FBS was determined in a drop of blood from the tail
using a glucometer (ACCU-CHECK, Roche, Germany)
for four successive weeks. Likewise, body weights were
recorded weekly, using a Triple Beam Balance, for
later analysis and in order to adjust the weights of
injected chicory extract powder according to the chan-
ging body weights.
Blood sampling and analysis
Blood collection (fasting) was conducted twice: Once, 10
days after treatment with chicory, when only 4 members
of each group were sacrificed; and a second time at the
end of study time (28 days after the start of treatment
with chicory extract) when the remaining 10 rats in each
group were sacrificed. Rats were anesthetized using
pentobarbital (40 mg/kg body weight dissolved in 50 ml
normal saline; i. p. injection) and blood (3–4 ml) was
taken from the heart. A sample (1ml) of the blood from
each animal was collected in EDTA containing tubes
(1.5 mg/ml) to be used for HbA1c measurement. The
remaining blood samples were used to prepare sera that
were stored at −80°C until used.
Fasting serum enzyme activities, ALT and AST, TG,
TC and total protein concentrations in blood samples
from days 10 and 28 were measured in Shariati Hospital
Pathology Lab by their respective kits (from Human
diagnostics, Germany) and HbA1c% was also determinedby kit (RANDOX, UK), using an automatic analyzer
(Hitachi 902, Japan-Germany). Insulin was determined by
Rat Insulin ELISA Kit according to the manufacturer’s
instructions (Mercodia, Sweden). Biochemical assay results
have been presented only for the final day of study
(day 28) due to similarity of the results (Table 2).
Nitric oxide determination
NO was measured by modified Griess reaction [25].
Briefly, serially diluted standards or deproteinated
serum samples, 2% sulfanilamide in 1M HCl, 0.1% N-
(1-Naphthyl)ethylenediamine in ddH2O, and then vana-
dium chloride solution (80 mg dissolved in 10 ml of 1M
HCl) were mixed (50 μl of each) in the mentioned order
in a 96-well plate. After 45 min of incubation at 37°C,
optical density was determined at 450 nm by a micro-
plate reader (2020 Anthos, Austria). NO concentrations
in the samples were determined using a standard cali-
bration curve. Deproteination of serum samples was
accomplished by 3000 MWCO VIVASPIN filters from
Sartorius (Germany).
Intraperitoneal glucose tolerance test (IPGTT)
Another set of rats (5 groups also named control, STZ,
NIA/STZ, chicory-STZ, and chicory-NIA/STZ, consist-
ing of 6 rats each and prepared as explained in section
of experimental diabetes above) was subjected to
IPGTT. A chicory-control group was not included in
this section of the study due to insufficient Rat Insulin
Elisa Kit. Briefly, after an overnight fast, FBS was mea-
sured in six normal rats (control). The rats were anaes-
thetized; glucose (2 g/body weight) together with
lyophilized extract of chicory (125 mg/body weight) were
dissolved in 30-units volume of normal saline and
injected intraperitoneally. Blood glucose was determined
every 30 minutes in a drop of blood from the tail; at the
same time, whole blood (1ml, every 30 min) was taken
from the heart and sera were prepared for insulin meas-
urement. The same procedure was conducted on two
other groups of rats, STZ and NIA/STZ, immediately
after being made diabetic. Because blood analysis on day
Figure 1 Mean weight by day for each group.
Table 2 Summary statistics of blood variables values after 28 days of i.p. chicory extract injection
Measured parameter Control Chicory-control NIA/STZ Chicory-NIA/STZ STZ Chicory-STZ
Weight 227.3 ± 15.2 247.6 ± 28.8 218.1 ± 21.2 242.6 ± 14.1 186.8 ± 13.7 229.9 ± 25.7
*AST 119.1 ± 20.1 128.6 ± 20.1 124.6 ± 28.6 126.0 ± 47.6 151.7 ± 64.9 103.7 ± 20.4
*ALTa†,b†,c‡,f† 43.7 ± 9.9 47.4 ± 11.9 46.2 ± 7.5 40.6 ± 9.0 87.8 ± 43.0 51.2 ± 15.7
TGa‡,b† 78.5 ± 31.7 83.3 ± 27.1 111.2 ± 38.1 82.8 ± 44.7 121.6 ± 26.9 97.3 ± 33.5
TCa†,b†d# 40.6 ± 9.9 43.0 ± 6.9 48.3 ± 7.7 51.3 ± 11.0 56.2 ± 9.6 49.6 ± 7.9
Total protein 6.10 ± 0.5 5.9 ± 0.2 6.0 ± 0.2 6.4 ± 0.6 5.8 ± 0.5 5.7 ± 0.5
HbA1caŦ,bŦ, d†,e†,fŦ 3.9 ± 0.2 3.9 ± 0.2 4.0 ± 0.4 4.0 ± 0.1 8.0 ± 2.3 6.5 ± 1.9
NOa‡, b#,c‡ 37.0 ± 4.6 37.0 ± 5.0 34.46.0 36.8 ± 4.0 31.2 ± 5.1 38.3 ± 6.4
FBS 77.7 ± 6.6 77.1 ± 3.0 159.2 ± 7.6 110.4 ± 8.5 416.5 ± 33.0 361 ± 86.1
Insulin 2.5 ± 0.4 2.5 ± 0.8 0.08 ± 0.3 0.8 ± 0.3 NA NA
Weight (gram), AST and ALT, specific activities of aspartate amino transferase and alanine amino transferase, (Units per grams protein); TG, triacylglycerol (mg/dl);
TC, total cholesterol (mg/dl); Total protein (g/dl); HbA1c, glycosylated hemoglobin (%); and NO, nitric oxide (μmol/dl), FBS, fasting blood sugar (mg/dl); Insulin
(μg/l). Data are presented as mean ± SD. NA Insulin concentrations were considered undetectable, as the values were negative −0.76 ± 0.3 and −0.66 ± 0.4 for
CS and TCS, respectively. i.p, intraperitoneal;* AST and ALT were adjusted by a division of Total protein values. acontrol vs. STZ; bchicory-control vs. STZ; cSTZ vs.
chicory-STZ; dcontrol vs. chicory-STZ; echicory-control vs. chicory-STZ, fSTZ vs. NIA/STZ; †p < 0.01; ‡p < 0.05; Ŧp < 0.001; #p ≤ 0.05.
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parameters as day 28, rats in groups chicory-STZ and
chicory-NIA/STZ were treated with chicory extract for
10 days prior to IPGTT.
Statistical analysis
The collected data essentially involved a 6 × 6 repeated
measures with treatment groups as between-subjects
factors and days of study as within-subjects factors. Data
for weight and FBS were summarized with mean ± SD.
Linear mixed effects models (SAS PROC MIXED) were
used as the primary tool for assessment followed by a
post-hoc least significance difference (LSD) for pair wise
comparisons. Minor imputation was done for missing
values. We assumed the unstructured covariance matrix
to carry out the analysis. Akaike's Information Criterion
(AIC) and Schwarz' Bayesian Criterion (SBC) were used
to determine the underlying covariance structure.
According to AIC, the autoregressive (AR1) of order 1
was used to model the covariance structure of longitu-
dinal measures on each rat in the linear mixed effect
model. Data of the blood variables on days 28 were pre-
sented as mean ± SD.
For the analysis of the 120 minutes follow-up data on
blood glucose and insulin, truncated polynomial spline
basis terms were introduced to model the nonlinearity and
change points seen in the longitudinal progression for
these measures. The area under curve (AUC) was deter-
mined by Image J Software (NIH) and compared using
Kruskal-Wallis Test (nonparametric ANOVA). A p-value
lower than 0.05 was considered statistically significant.
Results
Blood sugar after diabetes induction
Although non-fasting blood sugar was measured at
time zero, it can be inferred from following the FBS ofnon-diabetic groups (control and chicory-control) that
normal FBS is around 86.5 ± 7.17 to 87.64 ± 9.41
(Table 1). In late-stage diabetic rat groups (STZ and
chicory-STZ), a single STZ injection increased FBS
about 3.5-fold. When one STZ injection was followed by
a single injection of niacinamide (NIA), rats developed a
form of early stage diabetes mellitus and FBS increased
nearly 1.8-fold in NIA/STZ and chicory-NIA/STZ groups.
Weekly measurement of body weight
During the 4-wk treatment with chicory, the weight in
control and chicory-control groups increased signifi-
cantly (about 13%) as a result of ordinary growing up.
As shown in Figure 1, the weight loss was significant
(12.5%) in STZ group and negligible in NIA/STZ group
(4.5%). The mean weight remained nearly constant
during the study time in chicory-STZ group (1.6%
weight losses only). An overall comparison of the groups
across all time points suggested that chicory helped pre-
vent excessive weight loss in both early- and late-stage
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either since chicory extract administration to normal
healthy rats did not encourage any increase in weight
(chicory-control compared with control).
Chicory treatment prevented excessive weight loss in
both late and early stage of diabetes according to an
overall comparison STZ with chicory-STZ (one sided p
< 0.05) and NIA/STZ with chicory-NIA/STZ (one sided
p < 0.01) across all time points. Ŧ show statistically
significant differences between both control and chicory-
control with all other groups; *show significant differ-
ence between chicory-STZ and STZ-diabetic groups;
†show significant differences between chicory-NIA/STZ
and NIA/STZ. Treatment with chicory started on day 5
after STZ and STZ + NIA injections and lasted for
28 days, thus a total of 33 days of study.
Weekly measurements of FBS
FBS levels did not change in control and chicory-control
groups during 4-wk study time. FBS increased drastically
in STZ and moderately, but significantly, in NIA/STZ
groups. Chicory treated groups, chicory-STZ and chic-
ory-NIA/STZ, were able to resist excessive increases
in FBS (Figure 2). An overall comparison of the groups
across all time points indicated chicory’s ability to
lower blood sugar in both severe and mild diabetic
rats. Nonetheless, on the final day of study, FBS was
still much higher in chicory-STZ (final day vs. initial day:
p-value <0.0001).
The level of FBS remained mainly unchanged for con-
trol and chicory-control groups, increased considerably
in STZ and moderately in NIA/STZ diabetic rats. Treat-
ment with chicory extract lowered fasting blood sugar
level in STZ (late stage) and NIA/STZ (early stage) dia-
betic rats (one-sided p < 0.05 for STZ vs. chicory-STZ
and NIA/STZ vs. chicory-NIA/STZ groups). Body
weight was included as a covariate to reduce variability.
Ŧ show statistically significant differences between bothFigure 2 Mean FBS by day for each group.control and chicory-control with all other groups; *show
significant difference between chicory-STZ and STZ-
diabetic groups; † show significant differences between
chicory-NIA/STZ and NIA/STZ. Treatment with chic-
ory started on day 5 after STZ and STZ + NIA injections
and lasted for 28 days, thus a total of 33 days of study.
Blood parameters at the end of 4-wk study time
The results are summarized in Table 2. In STZ-diabetic
group, 4 wk after diabetes induction, significant
increases in ALT, TG, TC, HbA1c, and FBS and a signifi-
cant decrease in NO comprised the major complications.
In chicory-STZ group, daily chicory administration for
28 days, led to improvement of conditions even though
HbA1c and FBS were still higher than normal. In NIA/
STZ, the main variations included slight increases in TG
and TC. Over a 4 wk treatment with chicory extract, the
value of TG decreased toward normal. Total cholesterol
increased slightly further after treatment with chicory
for 28 days despite a decrease on day 10 after treatment.
IPGTT
According to Table 2, the effects of chicory on FBS and
Insulin were most obvious in NIA/STZ-diabetic rats.
In NIA/STZ, the remaining beta cells of the pancreas
were still producing some insulin, which despite being
significantly lower than normal (control vs. NIA/STZ,
p < 0.001) was keeping blood sugar concentration at
around 150 mg/dl. After treatment with chicory, insulin
levels increased in chicory-NIA/STZ (chicory-NIA/STZ
vs. NIA/STZ, p < 0.001 without and p < 0.05 with ad-
justment for weight).
The mean plots for blood glucose and insulin demon-
strate the progression patterns across different groups
(Figure 3A and B). Blood glucose levels stayed high and
insulin was undetectable in STZ and chicory-STZ groups
during the 120-minute follow up. In chicory-NIA/STZ
group, blood sugar values were lower and so close to con-
trol group that occasionally, at 30 and 90 min, the differ-
ence between control and chicory-NIA/STZ became
insignificant statistically. However, according to AUC,
total glucose showed a significant difference between con-
trol and NIA/STZ groups (P<0.001); but the AUCs for
NIA/STZ and chicory-NIA/STZ groups were not signifi-
cantly different (p>0.05).
According to Figure 3B, there was a significant
difference regarding the progression nonlinear pat-
terns among Control, NIA/STZ, and chicory-NIA/
STZ groups (p < 0.001). In terms of the change
point analysis, it could be confirmed that Control
had a peak or change point at min 30 (p < 0.0001);
chicory-NIA/STZ had a change point at min 60 (p
< 0.0001); and NIA/STZ had a peak or change point







































Figure 3 IPGTT. Mean plots for blood glucose (A) and insulin (B) by time. (A) Blood glucose follow-up for 120 minutes. Blood sugar levels in
NIA/STZ were statistically and significantly higher than control at all points in time during GTT (p < 0.0001). Chicory lowered blood sugar values
closer to control. (Control vs. chicory-NIA/STZ: initial, p <0.0001; 30 min, p > 0.05; 60 min, p = 0.01; 90 min, p = 0.05; 120 min, p < 0.001. NIA/STZ vs.
chicory-NIA/STZ: initial, p < 0.001; 30 min, p < 0.01; 60 min, p < 0.001; 90 min, p < 0.01; 120 min, p < 0.0001). (B) Blood insulin follow-up for
120 min. The timing of maximum insulin was 30 min, 60 min and 90 min for control, chicory-NIA/STZ, and NIA/STZ, respectively.
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cantly different in three groups (Table 3).Discussion
Early stage T2DM transformation to advance diabetes
occurs over time and is due to gradual destruction
of pancreatic β cells. As prevention is meant to inhibit
an abnormal condition from getting worse or to delay
the side effects of a disease, it seemed important to
us to investigate the effects of chicory seed extract on
early diabetes.IPGTT
The effect of chicory extract on GTT was the main
observation of this study, which is summarized in
Figures 3A and B. The comparison of GTT plots for
Control, NIA/STZ, and chicory-NIA/STZ groups may
suggest a relative improvement of insulin sensitivity and
a reduction of insulin resistance in the chicory-treated
group (chicory-NIA/STZ) (Figure 3B). Hyperinsulinemia
in NIA/STZ implies that peripheral tissue insulin resist-
ance occurred after partial beta cell destruction, while
the alleviation of hyperinsulinemia together with the
alleviation of ALT activity in the chicory-treated group
Table 3 Area under curve (AUC) for glucose and insulin in Figure 3
Area Under Curve (AUC) Control NIA/STZ Chicory-NIA/STZ STZ Chicory-STZ
Glucose 156524 ± 4099 178229 ± 6595 172765 ± 3354 195472 ± 2408 190161 ± 3828
Insulin 128189 ±10450 143380 ± 7985 123864 ± 7024 NA NA
AUC for glucose in control was significantly different than AUC for NIA/STZ (P<0.001). AUCs for insulin were not significantly different among the three groups,
p > 0.05). NA, non applicable.
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change in the peak insulin time point in chicory-NIA/
STZ compared to NIA/STZ (60 min vs. 90 min) is an
indication of a quicker response of the pancreatic beta
cells to postprandial hyperglycemia and further supports
chicory’s ability to stimulate insulin secretion form
pancreatic beta cells. The same effects are not observed
in chicory-STZ group presumably because of lack of
insulin in advanced diabetes. It can be argued that chic-
ory plays the role of an insulin-sensitizer and should also
be able to act in late stage diabetic patients who receive
exogenous insulin injections.
Blood parameters
Lack of insulin in chicory-STZ, however, did not stop
chicory’s long-term positive effects on blood parameters.
Deaths were prevented in chicory treated severe dia-
betes. The decrease in TG and TC in the blood of
chicory-STZ rats may be secondary to improved lipid
metabolism [27] and inhibition of adipogenesis [10]. In
chicory-NIA/STZ rats, the increase in TC over 28 days
of exposure to chicory extract may be due to an increase
in HDL-cholesterol according to Kim and Shin [27].
In our study, NO levels were found to be low in the
blood of diabetic rats. Several studies have shown that
patients with Type 2 diabetes have decreased endothelial
nitric oxide (eNO) production, and enhanced plasma con-
centrations of asymmetrical dimethylarginine (ADMA),
an inhibitor that suppresses eNO synthesis and produces
vascular dysfunction and neurological disorders [28]. As
NO is also an important player in the nervous system,
there may be a beneficial role of chicory in the prevention
of both cardiovascular and neurological implications of
diabetes, as it has been described for the aging myocar-
dium of albino rats and oxidative defense system in the
brain of diabetic rats [29,30].
The rise in the activity of liver enzymes ALT and AST
in blood is common in liver diseases; but several recent
studies have suggested the circulating ALT levels at the
upper range of normal limits and high ALT/AST ratios
to be associated with high prevalence of metabolic
syndrome, insulin resistance (IR) and obesity [26,31-33].
In this study, severe diabetes was accompanied by statis-
tically significant increase in ALT specific activities that
was lowered by chicory treatment, a confirmation of the
hepatoprotective properties of chicory and improvement
of metabolic syndrome and insulin resistance. ASTspecific activity and Total protein levels were sustained
according to Table 2, the former implying higher ALT/
AST ratios.
Glycosylated hemoglobin (HbA1c) that had almost
doubled in STZ rats indicated some reduction in the
chicory-treated late stage diabetes (chicory-STZ) mean-
ing that blood sugar levels were kept at relatively lower
levels under the influence of chicory extract. The obser-
vations related to blood parameters in severe diabetes
suggest that chicory may be also capable to act through
insulin-independent mechanisms.
Obesity is a risk factor for developing diabetes melli-
tus; but diabetes itself is accompanied by loss of weight
due to muscle wasting. Diabetic patients suffer from
negative nitrogen balance [34]. Chicory extract pre-
vented weight loss in both severe and mild diabetes.
Weight loss inhibition could be due to an easing of glu-
cose transportation into the peripheral tissue as a result
of possible correction of insulin resistance (in early
diabetes) and improved lipid metabolism (in late stage
diabetes); it cannot be ruled out, however, that chicory
extract components may also have further effects dir-
ectly on protein metabolism [35].
Unlike the bitter taste of chicory leaves and roots,
chicory seed decoction is palatable. Although many
studies have used alcoholic extract of chicory, home-
made preparations are usually made in water, as alcohol
is both toxic to the liver and prohibited in many
cultures. The glucose lowering capacity of chicory has
been attributed to its chemical composition including
antioxidant compounds [17], anthocyanins [36], tannins
[10], coumarins, chicoric acid, chlorogenic acid, and
caffeic acid [37]. The role of antioxidants in the man-
agement of diabetes and its complications has been
reviewed [38]. Chicory possesses a strong antioxidant
capacity; for the aqueous seed extract used in this
study, 1, 1-diphenyl-2-picryl hydrazyl radical (DPPH)-
50% inhibition (IC50) was calculated to be 180.5 μg/ml
by DPPH radical-scavenging assay [39]. Chicory contains
vitamins and many of the essential amino acids, and car-
bohydrates [9]. The effects of chicory seed extract
observed in this study are despite the presence of sugar
in the extract (total of approximately 183.7 mg soluble
sugar per g dry weight of stock powder, measured by
Kochert method [40]). The sugar in the seed extract
includes sucrose, and an oligosaccharide which was
shown by chromatographic analysis to consist of glucose
Ghamarian et al. DARU Journal of Pharmaceutical Sciences 2012, 20:56 Page 8 of 9
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fructose and sucrose has been measured by Jurgonskiet
al [41]; they also examined water-soluble and lipid-
soluble fractions of chicory peel and seed extract for
antioxidant capacity and their effects on the activities
of superoxide dismutase and glutathione peroxidase
enzymes [18,41].
Conclusions
The results of the present study suggest that chicory
may exert both short- and long-term effects on diabetes,
the former being under the influence of insulin and
through its insulin-sensitizing action. The long-term
beneficial effects of chicory may arise without the assist-
ance of insulin.
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